LLY

1,028

-1.37%↓

JNJ

245.17

-0.42%↓

ABBV

226.93

-0.59%↓

NVS

166.41

-0.16%↓

MRK

122.41

-1.23%↓

LLY

1,028

-1.37%↓

JNJ

245.17

-0.42%↓

ABBV

226.93

-0.59%↓

NVS

166.41

-0.16%↓

MRK

122.41

-1.23%↓

LLY

1,028

-1.37%↓

JNJ

245.17

-0.42%↓

ABBV

226.93

-0.59%↓

NVS

166.41

-0.16%↓

MRK

122.41

-1.23%↓

LLY

1,028

-1.37%↓

JNJ

245.17

-0.42%↓

ABBV

226.93

-0.59%↓

NVS

166.41

-0.16%↓

MRK

122.41

-1.23%↓

LLY

1,028

-1.37%↓

JNJ

245.17

-0.42%↓

ABBV

226.93

-0.59%↓

NVS

166.41

-0.16%↓

MRK

122.41

-1.23%↓

Search

McKesson Corp

Geschlossen

BrancheGesundheitswesen

960 0.36

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

949.38

Max

965.06

Schlüsselkennzahlen

By Trading Economics

Einkommen

40M

1.3B

Verkäufe

3B

106B

KGV

Branchendurchschnitt

26.954

110.024

Dividendenrendite

0.33

Gewinnspanne

1.177

Angestellte

43,000

EBITDA

374M

1.8B

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+3.42% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.33%

2.26%

Nächstes Ergebnis

7. Mai 2026

Nächste Dividendenausschüttung

1. Apr. 2026

Nächstes Ex-Dividendendatum

2. März 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

10B

115B

Vorheriger Eröffnungskurs

959.64

Vorheriger Schlusskurs

960

Nachrichtenstimmung

By Acuity

54%

46%

288 / 351 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bearish Evidence

McKesson Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

24. Feb. 2026, 23:07 UTC

Ergebnisse

Woolworths 1st Half Profit Hit By Worker Pay Dispute, Still Boosts Dividend

24. Feb. 2026, 23:01 UTC

Ergebnisse

Fortescue 1st Half Net Profit, Dividend Rise on Higher Shipments, Prices -- Update

24. Feb. 2026, 22:59 UTC

Ergebnisse

WiseTech to Cut 2,000 Jobs as It Asks AI to Boost Profitability -- Update

24. Feb. 2026, 22:42 UTC

Ergebnisse

WiseTech to Cut 2,000 Jobs as It Asks AI to Boost Profitability

24. Feb. 2026, 22:24 UTC

Akquisitionen, Fusionen, Übernahmen

Warner Bros. Discovery Board Says Paramount Skydance's New Proposal Could Top Netflix Agreement -- Update

24. Feb. 2026, 23:46 UTC

Market Talk

Gold Edges Higher Amid Possible Position Adjustments -- Market Talk

24. Feb. 2026, 23:36 UTC

Market Talk

Nikkei May Rise, Tracking Wall Street's Rebound -- Market Talk

24. Feb. 2026, 23:30 UTC

Market Talk

Fortescue's Copper Bet Is Long Term, While Iron Ore Remains Near-Term Driver -- Market Talk

24. Feb. 2026, 23:20 UTC

Market Talk

Fortescue Dividend Beat Overshadows Profit Miss -- Market Talk

24. Feb. 2026, 23:20 UTC

Market Talk

Global Equities Roundup: Market Talk

24. Feb. 2026, 23:16 UTC

Ergebnisse

Oversea-Chinese Banking Corp.'s CEO: "Looking Ahead, We Remain Cautious Yet Positive">O39.SG

24. Feb. 2026, 23:13 UTC

Ergebnisse

Oversea-Chinese Banking Corp. FY25 Non-Interest Income S$5.46B Vs. S$4.72B >O39.SG

24. Feb. 2026, 23:12 UTC

Ergebnisse

Oversea-Chinese Banking Corp.: FY25 Net Interest Income S$9.15B Vs. S$9.76B>O39.SG

24. Feb. 2026, 23:10 UTC

Ergebnisse

Oversea-Chinese Banking Corp. FY25 NPL Ratio 0.9%, Unchanged on Year>O39.SG

24. Feb. 2026, 23:10 UTC

Ergebnisse

Oversea-Chinese Banking Corp. FY25 Net Interest Margin 1.91%, Down 29bps on Year>O39.SG

24. Feb. 2026, 23:08 UTC

Ergebnisse

Oversea-Chinese Banking Corp. FY25 Net S$7.42B Vs. Net S$7.59B >O39.SG

24. Feb. 2026, 23:07 UTC

Ergebnisse

Oversea-Chinese Banking Corp. FY25 Total Income S$14.61B Vs. S$14.47B>O39.SG

24. Feb. 2026, 22:52 UTC

Ergebnisse

Woolworths 1H Profit Hit By Worker Pay Dispute, Still Boosts Dividend

24. Feb. 2026, 22:46 UTC

Ergebnisse

Fortescue 1H Net Profit, Dividend Rise on Higher Shipments, Prices -- Update

24. Feb. 2026, 22:31 UTC

Akquisitionen, Fusionen, Übernahmen

Warner Receives New Bid From Paramount -- 3rd Update

24. Feb. 2026, 22:29 UTC

Ergebnisse

Woolworths: FY Ebit Growth for Australian Food Expected at Upper End of Mid-to-High Single Digit Range Provided in August

24. Feb. 2026, 22:28 UTC

Ergebnisse

Woolworths: Australian Food Current Growth Rates Reflect Some Benefit from Cycling of Industrial Action Impacts

24. Feb. 2026, 22:27 UTC

Ergebnisse

Woolworths: Australian Food Sales +7.2% Excluding Tobacco in 2H First Seven Weeks

24. Feb. 2026, 22:27 UTC

Ergebnisse

Woolworths: Australian Food Sales +5.8% in 2H First Seven Weeks

24. Feb. 2026, 22:25 UTC

Ergebnisse

Woolworths: Customers Continue to be Value-Focused, Shopping Multiple Retailers in Highly Competitive Environment

24. Feb. 2026, 22:24 UTC

Ergebnisse

Woolworths: Trading in 3Q to Date Has Been Strong in Australian Food

24. Feb. 2026, 22:23 UTC

Ergebnisse

Woolworths 1H Group Sales A$37.1 Bln, Up 3.4%

24. Feb. 2026, 22:22 UTC

Ergebnisse

Woolworths Interim Dividend 45 Australian Cents/Share

24. Feb. 2026, 22:22 UTC

Ergebnisse

Woolworths 1H Profit Before Significant Items A$859 Mln, Up 16.4%

24. Feb. 2026, 22:21 UTC

Ergebnisse

Woolworths 1H Statutory Net Profit A$374 Mln, Down 49.4%

Peer-Vergleich

Kursveränderung

McKesson Corp Prognose

Kursziel

By TipRanks

3.42% Vorteil

12-Monats-Prognose

Durchschnitt 990.1 USD  3.42%

Hoch 1,107 USD

Tief 885 USD

Basierend auf 11 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für McKesson Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

11 ratings

9

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

681.92 / 707.28Unterstützung & Widerstand

Kurzfristig

Strong Bearish Evidence

Mittelfristig

No Evidence

Langfristig

No Evidence

Stimmung

By Acuity

288 / 351 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat